Transgenic animals and prion diseases: Hypotheses, risks, regulations and policies

New Zealand Veterinary Journal

Volumn 44, Issue 1, 1996, Pages 33-36

  Wills, P R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007857502     PISSN: 00480169     EISSN: 11760710     Source Type: Journal    
DOI: 10.1080/00480169.1996.35929     Document Type: Article

References (23)

1. Wills PR. Transgenic animals and prion diseases. New Zealand Veterinary Journal 43, 86-7,1995.
2. O’Neil BD. Transgenic animals and prion diseases. New Zealand Veterinary Journal 43,88,1995.
3. Weissmann C. A ‘unified theory’ of prion propagation. Nature 352, 679-683,1991.
4. Prusiner SB. The prion diseases. Scientific American 272(1), 30-7, 1995.
5. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375, 698-700,1995.
6. Wills PR. Prions and theory in molecular biology. Seminars in Virology 2,181-7,1991.
7. Wills PR. Scrapie, ribosomal proteins and biological information. Journal of Theoretical Biology 122,157-78,1986.
8. Wills PR. Genetic information and the determination of functional organisation in biological systems. Systems Research 6, 219-26,1989.
9. Tuite MF. Psi no more for yeast prions. Nature 370,327-8,1994.
10. Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ. Evidence for the experimental transmission of cerebral B-amyloidosis to primates. International Journal of Experimental Pathology 74, 44154,1993.
11. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 216,136-44,1982.
12. Wills PR. Quantitative constraints on mechanisms of replication for information-carrying prions. In: Iqbal K, Wisniewski HM, Winblad B (eds). Alzheimer’s Disease and Related Disorders, Alan R Liss, New York, 1989.
13. Stiers RN. Defective protein folding as a cause of disease. Structural Biology 2, 355-7,1995.
14. Milner J. Flexibility: The key to p53 function? Trends in Biochemical Science 20, 49-51,1995.
15. Ragg M. Gland bomb set to explode. The Bulletin 116 (5924), 34, 14 June 1994.
16. Dawkins R. The Blind Watchmaker. WW Norton & Co., New York, 1986.
17. Wills PR. Correcting evolution: biotechnology’s unfortunate agenda. Revue Internationale de Systemique 8,455-68,1994.
18. Genzyme Transgenics Corporation. Protein Development and Production Services. Genzyme, Framington, Massachusetts, 1993.
19. Bullock DW. Proposal to field test genetically modified goats. Interim Assessment Group Document O 2-1-3-1, 1993.
20. Lincoln University. Nature wasn’t his only mother. Time (49), 5, 5 December 1994.
21. Anon. A biotech bonanza on the hoof? Science 259,1698,1993.
22. Genpharm International. Production of recombinant polypeptides by bovine species and transgenic methods. New Zealand Patent No. 236310,1-86,27 September 1993.
23. Brien C. European Parliament axes patent policy. Science 267, 1417-8,1995.